LungLife AI, Inc (DI) (LLAI) Short Positions
Add to Alert list

Active Short Positions

Holder Position Change Date
No active short positions

Historical Short Positions

Holder Position Change (%) Date
No historical short positions

LungLife AI is a molecular diagnostics company focused on developing AI-enabled blood tests for the early detection of lung cancer.

LungLife share price was cancelled in May 2025.

Note: This description is in part generated by AI and not an endorsement by or the opinion of Investegate
UK 100

Latest directors dealings